Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Jul-Aug;36(4):466-476.
doi: 10.20524/aog.2023.0811. Epub 2023 May 30.

Cutaneous Crohn's disease after proctocolectomy for medically refractory colonic Crohn's disease: a case series and review of the literature

Affiliations
Case Reports

Cutaneous Crohn's disease after proctocolectomy for medically refractory colonic Crohn's disease: a case series and review of the literature

Sandra Naffouj et al. Ann Gastroenterol. 2023 Jul-Aug.

Abstract

Background: Cutaneous Crohn's disease (CCD), also known as metastatic Crohn's disease (CD), is one of the rarest and most challenging cutaneous manifestations of CD. It is characterized by non-caseating granulomatous inflammation of the skin at sites that are non-contiguous with the gastrointestinal (GI) tract. Diagnosis of CCD needs a high clinical suspicion since morphological presentation varies widely and lacks an apparent correlation to the activity of the luminal CD. The onset of CCD in patients without active GI CD is a particularly understudied phenomenon.

Methods: We present a case series of a unique patient group who developed CCD while in remission from a luminal CD perspective, mainly after a proctocolectomy for Crohn's colitis. We also provide a literature review and summary of case reports of CCD after proctocolectomy.

Results: Our 4 adult patients diagnosed with CCD after proctocolectomy presented herein, were successfully treated with high-dose corticosteroids, followed by biologic therapy. Furthermore, a comprehensive review of CCD is provided regarding its pathogenesis, clinical presentation, differential diagnosis, and the evidence behind the available treatments.

Conclusions: CCD should be considered in any CD patient presenting with skin lesions regardless of their disease activity status and history of proctocolectomy. The treatment remains challenging; biologics remain the cornerstone and a multidisciplinary approach is recommended. Larger randomized clinical trials are essential to determine the optimal treatment protocol and to improve outcomes.

Keywords: Cutaneous Crohn’s disease; dermatologic manifestations; inflammatory bowel disease; metastatic Crohn’s disease; proctocolectomy.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None

Figures

Figure 1
Figure 1
(A, B) Patient 1: pre- and post-treatment of ulcerated, linear “knife-like” lesion in the right groin consistent with cutaneous Crohn’s disease (C, D, E, F) patient 1 pathology images: cutaneous ulceration with diffuse marked acute and chronic inflammation associated with loose granulomas, involving dermis and subcutaneous tissue consistent with cutaneous Crohn’s disease. (G, H) Patient 2: pre- and post-treatment of ulcerated, linear “knife-like” lesion in the gluteal cleft consistent with cutaneous Crohn’s disease. (I, J) Patient 3: pre- and post-treatment of erythematous fissured plaque with purulence in the gluteal cleft consistent with cutaneous Crohn’s disease. (K, L) Patient 4: pre- and post-treatment of a groin wound in cutaneous Crohn’s disease
Figure 2
Figure 2
Suggested algorithm for approach and management of cutaneous Crohn’s disease post-proctocolectomy TNF, tumor necrosis factor; IL, interleukin

Similar articles

Cited by

References

    1. Siroy A, Wasman J. Metastatic Crohn disease:a rare cutaneous entity. Arch Pathol Lab Med. 2012;136:329–332. - PubMed
    1. Kafity AA, Pellegrini AE, Fromkes JJ. Metastatic Crohn's disease. A rare cutaneous manifestation. J Clin Gastroenterol. 1993;17:300–303. - PubMed
    1. Emanuel PO, Phelps RG. Metastatic Crohn's disease:a histopathologic study of 12 cases. J Cutan Pathol. 2008;35:457–461. - PubMed
    1. Greuter T, Navarini A, Vavricka SR. Skin manifestations of inflammatory bowel disease. Clin Rev Allergy Immunol. 2017;53:413–427. - PubMed
    1. Bohdanowicz M, Ghazarian D, Rosen CF. Cutaneous Crohn's disease of the vulva after a total colectomy and without gastrointestinal manifestations:a case report. SAGE Open Med Case Rep. 2019;7:2050313X19868390. - PMC - PubMed

Publication types

LinkOut - more resources